Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Bill Newlin
AddedMar 31, 2024
UpdatedMay 31, 2026
Bill Newlin

Bill Newlin

Board Member, Newlin Investment

Crunchbase

Bill Newlin's Career

Newlin Investment
Newlin Investment

Sewickley, PA, US

Board Member· Board
Sharp Edge Labs
Sharp Edge Labs

Pittsburgh, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Bill Newlin's Career

Newlin Investment
Newlin Investment
Investment Firm62007Sewickley, PA, US
Board Member· Board

Leadership at Newlin Investment

William J LyonsWilliam J LyonsBoard Member

Similar to Newlin Investment

New Capital FundNew Capital FundLittle Chute, WI, USest. 2006New Capital FundLittle Chute, WI, US · est. 2006

NEW Capital Fund, LP: A US-based private equity and venture capital firm investing in niche industries and advanced tech.

7
NewRoad Capital PartnersNewRoad Capital PartnersRogers, AR, USest. 2013NewRoad Capital PartnersRogers, AR, US · est. 2013

NewRoad Capital Partners: A US-based venture capital firm investing in retail, supply chain, data, health, and manufacturing sectors.

36
Newlight PartnersNewlight PartnersNew York City, NY, USest. 2018Newlight PartnersNew York City, NY, US · est. 2018

Newlight Partners: A growth-focused private equity firm, building successful businesses across sectors for over 15 years.

39
Newland Capital GroupNewland Capital GroupIrvine, CA, USNewland Capital GroupIrvine, CA, US

Employee-owned hedge fund sponsor - Newland Capital Group.

2
Sharp Edge Labs
Sharp Edge Labs
Series A$4.6M82010Pittsburgh, PA, US
Board Member· Board

Leadership at Sharp Edge Labs

Scott SneddonScott SneddonCEO
Alan WaggonerAlan WaggonerFounder

Similar to Sharp Edge Labs

Innovative BiosensorsInnovative BiosensorsRockville, MD, USBioassays, Biosensorsest. 2003Innovative BiosensorsRockville, MD, US · est. 2003

Provider of innovative, rapid biosensor technology for cost-effective, on-site bioassays with high sensitivity and specificity.

Seed · $20.2M11
Efferent LabsEfferent LabsBuffalo, NY, USBiosensors, Medical Devicesest. 2013Efferent LabsBuffalo, NY, US · est. 2013

Efferent Labs: A pre-clinical med-tech company specializing in implantable biosensors.

Angel · $900k5
StemloopStemloopEvanston, IL, USBiosensorsest. 2019StemloopEvanston, IL, US · est. 2019

Stemloop: A cell-free platform creating biosensors for external cell operation.

Pre-Seed · $2.3M7
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615

People Similar to Bill Newlin

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · KakaoJoann EisenhartJoann EisenhartBoard Member · PlexusNelson ChanNelson ChanBoard Member · Twist BioscienceMichael LaxMichael LaxBoard Member · Autronic PlasticsDennis ChookaszianDennis ChookaszianBoard Member · SnapsheetDick KramlichDick KramlichBoard Member · Visual Edge TechnologyByron AlsbergByron AlsbergCo-Founder · Prefix Capital